Sign Out
Patients with type 2 diabetes mellitus (T2DM).
Galvus Met is indicated as an adjunct to diet and exercise in patients whose blood glucose is not adequately controlled on metformin hydrochloride or vildagliptin alone, or in patients already being treated with a free combination of metformin hydrochloride and vildagliptin.
Galvus Met is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients whose blood glucose is not adequately controlled on metformin and a sulphonylurea alone.
Galvus Met is indicated in combination with insulin to improve glycaemic control in patients whose blood glucose cannot be adequately controlled by diet, exercise and treatment with a stable dose of insulin and metformin.
